A new study funded by the Israel Cancer Association, the European Research Council (ERC) and the Kahn foundation, conducted by Prof. Ronit Satchi-Fainaro, Chair of the Department of Physiology and Pharmacology at the Sackler Faculty of Medicine, Head of the Cancer Angiogenesis and Nanomedicine Laboratory in Tel Aviv University, led to a breakthrough in glioblastoma research.Read the full announcement here.
Read the scientific article here